Similar articles for PMID: 31644159

Year	Number of Results
1999	1
2000	1
2002	2
2003	3
2004	2
2005	6
2006	3
2007	4
2008	3
2009	10
2010	11
2011	9
2012	11
2013	12
2014	8
2015	3
2016	6
2017	8
2018	4
2019	1
2020	1
2021	1
2022	2
2023	2
2024	0

1

[No authors listed] [No authors listed] 2017 Feb 10. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Feb 10. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644159 Free Books & Documents. Review.

2

TNF-alpha inhibitors for ankylosing spondylitis.

Maxwell LJ, Zochling J, Boonen A, Singh JA, Veras MM, Tanjong Ghogomu E, Benkhalti Jandu M, Tugwell P, Wells GA. Maxwell LJ, et al. Cochrane Database Syst Rev. 2015 Apr 18;(4):CD005468. doi: 10.1002/14651858.CD005468.pub2. Cochrane Database Syst Rev. 2015. PMID: 25887212 Review.

3

Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs.

Lee YH, Bae SC, Song GG. Lee YH, et al. Int J Rheum Dis. 2013 Oct;16(5):527-31. doi: 10.1111/1756-185X.12154. Int J Rheum Dis. 2013. PMID: 24164839 Review.

4

Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population.

Schabert VF, Watson C, Joseph GJ, Iversen P, Burudpakdee C, Harrison DJ. Schabert VF, et al. J Manag Care Pharm. 2013 Oct;19(8):621-30. doi: 10.18553/jmcp.2013.19.8.621. J Manag Care Pharm. 2013. PMID: 24074008 Free PMC article.

5

TNF-α antagonists beyond approved indications: stories of success and prospects for the future.

Karampetsou MP, Liossis SN, Sfikakis PP. Karampetsou MP, et al. QJM. 2010 Dec;103(12):917-28. doi: 10.1093/qjmed/hcq152. Epub 2010 Aug 27. QJM. 2010. PMID: 20802008 Review.

6

[Autoimmune aspects of treatment with TNF-alpha inhibitors].

Kolarz B, Targońska-Stepniak B, Darmochwał-Kolarz D, Majdan M. Kolarz B, et al. Postepy Hig Med Dosw (Online). 2007 Aug 28;61:478-84. Postepy Hig Med Dosw (Online). 2007. PMID: 17786135 Free article. Review. Polish.

7

Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics.

Chiu YM, Chen DY. Chiu YM, et al. Expert Rev Clin Immunol. 2020 Feb;16(2):207-228. doi: 10.1080/1744666X.2019.1705785. Epub 2020 Jan 11. Expert Rev Clin Immunol. 2020. PMID: 31852268 Review.

8

Molecular mechanisms of action of anti-TNF-α agents - Comparison among therapeutic TNF-α antagonists.

Mitoma H, Horiuchi T, Tsukamoto H, Ueda N. Mitoma H, et al. Cytokine. 2018 Jan;101:56-63. doi: 10.1016/j.cyto.2016.08.014. Epub 2016 Aug 24. Cytokine. 2018. PMID: 27567553 Review.

9

Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide series.

Toussirot É, Houvenagel É, Goëb V, Fouache D, Martin A, Le Dantec P, Dernis E, Wendling D, Ansemant T, Berthelot JM, Bader-Meunier B, Kantelip B; Le CRI. Toussirot É, et al. Joint Bone Spine. 2012 Oct;79(5):457-63. doi: 10.1016/j.jbspin.2011.10.001. Epub 2011 Nov 15. Joint Bone Spine. 2012. PMID: 22088934

10

TNF alpha inhibition as treatment modality for certain rheumatologic and gastrointestinal diseases.

Wiedmann MW, Mössner J, Baerwald C, Pierer M. Wiedmann MW, et al. Endocr Metab Immune Disord Drug Targets. 2009 Sep;9(3):295-314. doi: 10.2174/187153009789044347. Epub 2009 Sep 1. Endocr Metab Immune Disord Drug Targets. 2009. PMID: 19594416 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year